PENNY WATCH

[goodibag]

OMHE_is_Ready_to_Start_Licensed_Medical_Marijuana_Cultivation

On 2/9/2017 OMHE CEO released 1st letter (Click Here to Read) to shareholders and most of the promises have been fulfilled as we can see Here and here in this 11/14/2017 CEO's 2nd Letter. One more the most important promise was licensed medical marijuana cultivation plan and I am expecting that will be implemented in next few months.

From 2/9/2017 Letter

We will continue to innovate and continue to build on what we've accomplished. To do so, our vision is to capitalize on decades of knowledge and experience to create a global health and wellness company. To that end, we plan to rapidly expand our operations to include new divisions in the areas of (1) specialty pharmaceuticals, (2) anti-aging brands, and (3) therapeutic cannabis products and (4) licensed medical marijuana cultivation. Currently, we are in the final states of several strategic acquisitions to accelerate our bold expansion. Our pipeline of new products and breakthrough innovation has never been more robust.

Status, as of Nov 2017

(1) Specialty Pharmaceuticals –----------------- Completed - Click here to see proof
(2) Anti-Aging Brands –---------------------------- Completed - Click here to see proof
(3) Therapeutic Cannabis Products –---------- Completed - Click here to see proof
(4) Licensed Medical Marijuana Cultivation – INPROGRESS – WILL BE ANNOUNCED SOON


******OMHE_Developed_Cannabinoid-Based_Medicine


Link To News

The first, which we can share now, is development in the sphere of a cannabinoid-based drug-development. In collaboration with Dr. Karyemaitre Aliffe, MD, Omni Health is finalizing a regulatory path to commercialization of a breakthrough, proprietary compound agent with the potential to treat chronic pain.

We will continue to provide updates over the coming weeks that will include a collaboration/joint venture with one of the largest European cannabis companies pertaining to the import and distribution of breakthrough cannabidiol-centered consumer products that we are presently developing for them. The first steps in the commercialization process will involve the establishment of a strong presence in the European market, the benefits of which will be elaborated upon in future communications.

Other expected major events include OTCQB uplist, share restructuring etc.

Check at OTC Site



OMHE PPS Ready to Rise to $1